Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

TPEX:3218 Revenue

Universal Vision Biotechnology had revenue of 1.02B TWD in the quarter ending September 30, 2025, a decrease of -5.08%. This brings the company's revenue in the last twelve months to 4.21B, up 0.62% year-over-year. In the year 2024, Universal Vision Biotechnology had annual revenue of 4.23B with 3.58% growth.

• Revenue (ttm): 4.21B
• Revenue Growth: +0.62%
• P/S Ratio: 2.97
• Revenue / Employee: 10.50M
• Employees: 401
• Market Cap: 12.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.23B	146.05M	3.58%
Dec 31, 2023	4.08B	588.20M	16.83%
Dec 31, 2022	3.49B	862.26M	32.76%
Dec 31, 2021	2.63B	578.66M	28.18%
Dec 31, 2020	2.05B	634.16M	44.69%